We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
(+9.3%)
Cap. Flow
+$518M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$68M |
| 2 |
Truist Financial
TFC
|
+$55.9M |
| 3 |
ServiceNow
NOW
|
+$33.3M |
| 4 |
Uber
UBER
|
+$21.4M |
| 5 |
Las Vegas Sands
LVS
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$119M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$55.9M |
| 3 |
Apple
AAPL
|
+$48.3M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$22M |
| 5 |
VIAB
Viacom Inc. Class B
VIAB
|
+$16.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 15.53% |
| 3 | Healthcare | 13.38% |
| 4 | Consumer Discretionary | 10.07% |
| 5 | Industrials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBL
451
DELISTED
Noble Energy, Inc.
NBL
| $21.8M | 0.04% |
877,914
+30,703
| +4% | +$652K |
|
452
Jacobs Solutions
J
$16.3B
| $21.8M | 0.04% |
293,082
+30,779
| +12% | +$2.33M |
|
|
CY
453
DELISTED
Cypress Semiconductor
CY
| $21.7M | 0.04% |
929,812
-10,280
| -1% | -$240K |
|
454
Huntington Ingalls Industries
HII
$12.9B
| $21.7M | 0.04% |
86,330
+3,657
| +4% | +$867K |
|
455
American Financial Group
AFG
$11.8B
| $21.6M | 0.04% |
197,394
+1,706
| +0.9% | +$183K |
|
456
C.H. Robinson
CHRW
$17.2B
| $21.6M | 0.04% |
276,097
+9,408
| +4% | +$749K |
|
457
Nasdaq
NDAQ
$52.2B
| $21.6M | 0.04% |
604,491
+24,918
| +4% | +$849K |
|
458
Norwegian Cruise Line
NCLH
$8.88B
| $21.6M | 0.04% |
369,317
+14,181
| +4% | +$748K |
|
459
Regency Centers
REG
$14.6B
| $21.6M | 0.04% |
341,787
+34,621
| +11% | +$2.27M |
|
460
DexCom
DXCM
$32.6B
| $21.3M | 0.04% |
388,864
+8,208
| +2% | +$389K |
|
|
XYZ
461
Block Inc
XYZ
$48.6B
| $21.3M | 0.04% |
339,863
+15,988
| +5% | +$1.02M |
|
462
Lumentum
LITE
$59.3B
| $21.3M | 0.04% |
268,039
+10,327
| +4% | +$676K |
|
463
Avery Dennison
AVY
$13B
| $21.1M | 0.04% |
161,556
+7,345
| +5% | +$927K |
|
464
Universal Health Services
UHS
$10.3B
| $21.1M | 0.04% |
147,277
-772
| -0.5% | -$110K |
|
465
Gentex
GNTX
$5B
| $21.1M | 0.04% |
727,773
-188
| -0% | -$5.29K |
|
466
Charles River Laboratories
CRL
$11.1B
| $21.1M | 0.04% |
138,007
+3,104
| +2% | +$430K |
|
467
AES
AES
$10.5B
| $21.1M | 0.04% |
1,059,326
+44,609
| +4% | +$798K |
|
468
Pinnacle West Capital
PNW
$12.2B
| $21M | 0.04% |
233,911
+7,839
| +3% | +$707K |
|
469
Henry Schein
HSIC
$9.9B
| $21M | 0.04% |
314,901
+5,645
| +2% | +$373K |
|
470
Chemed
CHE
$7.14B
| $21M | 0.04% |
47,827
-66
| -0.1% | -$27.8K |
|
471
Reliance Steel & Aluminium
RS
$20.7B
| $21M | 0.04% |
175,303
+7,715
| +5% | +$873K |
|
472
Lear
LEA
$6.4B
| $20.9M | 0.04% |
152,532
+81,862
| +116% | +$10.1M |
|
|
CTLT
473
DELISTED
CATALENT, INC.
CTLT
| $20.8M | 0.03% |
370,091
+6,044
| +2% | +$308K |
|
|
MASI
474
DELISTED
Masimo
MASI
| $20.8M | 0.03% |
131,672
-991
| -0.7% | -$149K |
|
475
Eastman Chemical
EMN
$8.22B
| $20.8M | 0.03% |
262,291
+8,158
| +3% | +$627K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
- RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
- RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
- RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
- RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
- RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
- RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.
Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.